Table 4.
Detection of PorPV and viral load RNA in BALF, secondary lymphoid organs (SLO), and respiratory tissues (RT) in PorPV/Mock and PorPV/swH1N1 groups.
| Sample | Number of positive and viral load of PorPV |
|||||
|---|---|---|---|---|---|---|
| PorPV/Mock group |
PorPV/swH1N1 group |
PorPV/Mock group |
PorPV/swH1N1 group |
|||
| 46 DPI | 52DPI | |||||
| BALF | 2/2 (4.32 ± 1.11) | 0/3 | 0/3 | 0/3 | ||
| SLO | ||||||
| Tonsil | 3/3 (5.02 ± 0.26) | 3/3 (6.64 ± 0.58) | 3/3 (5.60 ± 0.16) | 3/3 (6.54 ± 1.13) | ||
| ML | 2/3 (4.34 ± 0.33) | 3/3 (6.88 ± 1.44) | 3/3 (5.88 ± 0.72) | 3/3 (5.86 ± 0.44) | ||
| TBL | 2/3 (5.42 ± 0.46) | 3/3 (5.09 ± 0.13) | 3/3 (5.36 ± 0.60) | 3/3 (6.56 ± 1.01) | ||
| Mean and SDa | 3.84 ± 2.22 | 6.20 ± 1.14 | 5.61 ± 0.53 | 6.32 ± 0.86 | ||
| SEM | 0.74 | 0.38 | 0.17 | 0.28 | ||
| P value | 0.015* | 0.055 | ||||
| RT | ||||||
| NM | 3/3 (3.88 ± 0.44) | 3/3 (4.59 ± 0.89) | 1/3 (3.74) | 3/3 (4.22 ± 0.24) | ||
| Trachea | 3/3 (4.67 ± 0.87) | 0/2 | 1/2 (5.13) | 2/3 (3.64 ± 0.48) | ||
| BT | 2/3 (3.89 ± 0.20) | 0/3 | 1/3 (3.87) | 1/2 (4.85) | ||
| Lung | 3/3 (3.39 ± 0.13) | 2/3 (3.91 ± 0.12) | 2/3 (3.86 ± 0.88) | 3/3 (4.28 ± 0.61) | ||
| Mean and SD | 3.63 ± 1.31 | 1.96 ± 2.30 | 1.85 ± 2.18 | 3.42 ± 1.75 | ||
| SEM | 0.37 | 0.69 | 0.65 | 0.52 | ||
| P value | 0.052 | 0.08 | ||||
BALF: bronchoalveolar lavage fluid. ML: mediastinal lymph node. TBL: tracheobronchial lymph node. NM: nasal mucosa. BT: bronchial trachea.
*
Indicates that the PorPV/swH1N1group is significantly different from the PorPV/Mock group (P < 0.05).
a
Mean and standard deviation (SD) of the total viral load in analysed samples for SLO or RT tissues. () Mean ± SD of PorPV copies/mL of total RNA (log10) in positive samples.